Phase I trial of personalized mRNA vaccine encoding neoantigen in patients with advanced digestive system neoplasms.

e15269Background: Cancer cells have characteristics of genetic instabilities and accumulate somatic mutations rapidly which could produce tumor specific antigens (TSAs) called as neoantigens. As th...